News und Analysen
DGAP-Adhoc: Ad hoc: MorphoSys AG meldet nicht zahlungswirksame Wertminderung des Geschäfts- oder Firmenwertes von 231 Mio. € nach F&E Konsolidierung; entsprechende Erhöhung des operativen Konzernaufwands in 2021
DGAP-Adhoc: Ad hoc: MorphoSys AG reports non-cash impairment charge of € 231 million on goodwill after consolidation of research and discovery functions; corresponding increase of Group operating expenses in 2021
DGAP-Adhoc: Ad hoc: MorphoSys AG reports non-cash impairment charge of € 231 million on goodwill after consolidation of research and discovery functions; corresponding increase of Group operating expenses in 2021
DGAP-Adhoc: Ad hoc: MorphoSys AG meldet nicht zahlungswirksame Wertminderung des Geschäfts- oder Firmenwertes von 231 Mio. € nach F&E Konsolidierung; entsprechende Erhöhung des operativen Konzernaufwands in 2021
Xencor to Present Preclinical Data from XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will
DGAP-News: Evotec presents strategic roadmap towards precision medicine and confirms goals of Action Plan 2025 at Capital Markets Day
DGAP-News: Evotec präsentiert strategischen Fahrplan für Präzisionsmedizin und bestätigt Ziele des Aktionsplans 2025 auf dem Capital Markets Day
Premier, Inc. to Participate in Upcoming Investor Conferences
Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, announced today that members of its management team are scheduled to participate in the following investor
DGAP-News: Evotec erweitert molekulare Patientendatenbank mit einzigartiger Nephrologie-Kohorte der Universität Bristol
DGAP-News: Evotec expands molecular patient database with unique nephrotic syndrome cohort from the University of Bristol
Acadia Healthcare Reports Fourth Quarter 2021 Results
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the fourth quarter and year ended December 31, 2021.
Fourth Quarter Highlights
-
Revenue totaled $593.5
LivaNova Announces First Patient Implanted in OSPREY Clinical Study for Patients Coping with Obstructive Sleep Apnea
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced the first patient implanted in the investigational device exemption (IDE) clinical study
Novocure’s General Counsel Resigns After 10 Years of Service
Novocure (NASDAQ: NVCR) today announced that Todd Longsworth, General Counsel, has resigned. Mr. Longsworth’s last day as General Counsel will be March 31. He will stay onboard as a Senior Legal
New Data Finds Tumor Treating Fields Initiates Downstream Anti-Tumor Response
Novocure (NASDAQ: NVCR) today announced that a new study published in the Journal of Clinical Investigation (JCI) finds treatment with Tumor Treating Fields (TTFields) mediated cell disruption
Novocure Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Company Update
Novocure (NASDAQ: NVCR) today reported financial results for the fourth quarter and full year ended December 31, 2021. Novocure is a global oncology company working to extend survival in some of
Xencor Reports Fourth Quarter and Full Year 2021 Financial Results
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported financial
LivaNova Reports Fourth-Quarter and Full-Year 2021 Results
LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today reported results for the quarter and full year ended December 31, 2021.
For the fourth quarter of
ICON Reports Fourth Quarter and Full Year 2021 Results
ICON plc (NASDAQ:ICLR), a world-leading healthcare intelligence and clinical research organisation, today reported its financial results for the fourth quarter and full year ended December 31
ICON plc to Present at the 2022 Citi Healthcare Conference
ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced that Mr. Brendan Brennan, CFO of ICON plc, will present at the 2022 Citi
DGAP-News: Gerresheimer AG: Gerresheimer accelerates growth and raises mid-term guidance
DGAP-News: Gerresheimer AG: Gerresheimer beschleunigt Wachstum und hebt mittelfristige Prognose an
Xencor to Report Fourth Quarter and Full Year 2021 Financial Results and Host Conference Call on February 23, 2022
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of patients with cancer and autoimmune diseases
Acadia Healthcare Announces Date for Fourth Quarter and Year-End 2021 Earnings Release
Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that it will release its fourth quarter and year-end 2021 results on Monday, February 28, 2022, after the close of the market. Acadia
Premier Inc. to Participate in 2022 SVB Leerink Global Healthcare Conference on February 16, 2022
Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, announced today that members of its management team are scheduled to participate in a virtual fireside chat
Premier Inc. Receives 2022 Best in KLAS Award for Value-Based Care Consulting
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement and technology company, has been awarded the 2022 Best in KLAS designation for Value-Based Care Consulting. The award was announced in